Pre-clinical Models in Oncology

Making the choice of apt preclinical model considering the similarity to human biology and disease genotypic and phenotypic characters that it carries, marks a considerable potential to ensure higher predictability of preclinical research. The designing and interpretation of trials on human volunteers is a major challenge in the development of novel anticancer agents. Key study design elements like schedule, doses, dose administration, escalation strategy, targeted patient population, etc. rely heavily on preclinical data. This scenario requires cautious decisions on the predictability of preclinical tumor models as well as the method of analysis and translation of the results of preclinical studies. It is surely a challenging task to model for preclinical assessment of cancer immunotherapy, the most actively developing area in oncology. The need for stimulating the response of the immune system adds to the complexity of preclinical models and the applications.

  • Prevent DNA Synthesis
  • Disrupt DNA
  • Protein Inhibitors
  • Interrupt Mitosis
  • Immune System Modifiers
  • Alteration of Protein Function
  • Angiogenesis Inhibitors
  • Differentiating Agents
  • Hormone Function Interference
  • Supporting Agents

Related Conference of Pre-clinical Models in Oncology

April 20-21, 2018

4th International Conference on Antibiotics: R&D, B2B

Las Vegas, Nevada, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

15th Annual European Pharma Congress

Frankfurt, Germany
June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
June 27-28, 2018

International Conference on Pharmaceutical Analysis and Quality Control Strategies

Vancouver, British Columbia, Canada
July 16-17, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 18-19, 2018

International Conference on Pharmaceutical Oncology

Atlanta, Georgia, USA
July 18-20, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
Jul 30-Aug 01, 2018

10th World Congress on Pharmacology

Barcelona, Spain
August 15-17, 2018

14th World Congress on Pharmacology and Drug Safety

Stockholm, Sweden
September 07-08, 2018

5th Annual Congress on Clinical Pharmacy & Pharmacology

Tokyo, Japan
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic
September 14-15, 2018

Annual Neurochemistry and Neuropharmacology Congress

Richmond, Virginia, USA
September 17-18, 2018

5th International Conference on Clinical Pharmacy and
Health Care

San Antonio, Texas, USA
September 17-18, 2018

11th World Congress on Pharmacology & Therapeutics

| San Antonio, Texas, USA
September 17-18, 2018

Gulf Congress on Pharmacy and Pharmaceutical Sciences

Abu Dhabi, UAE
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 17-18, 2018

Drug Formulation Congress 2018

Singapore
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Drug Delivery Systems

Prague, Czech Republic
September 24-25, 2018

World Congress on Traditional and Complementary Medicine

Abu Dhabi, UAE
September 24-26, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 28-29, 2018

11th World Congress on Pharmaceutical Sciences

| Montreal, Canada
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
November 08-09, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Frankfurt, Germany

Pre-clinical Models in Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in